Six RCTs were included (one was a cluster RCT). The number of participants was not reported. Follow-up ranged from one to 10 years. Risk of bias varied between trials. The main limitations were lack of blinding and loss to follow-up.
Health checks were associated with small but statistically significant improvements in total cholesterol (MD -0.13 mmol/L, 95% CI -0.19 to -0.07; four trials; Ι²=52%), systolic blood pressure (MD -3.65 mmHg, 95% CI -6.5 to -0.81; four trials; Ι²=94%), diastolic blood pressure (MD -1.79 mmHg, 95% CI -2.93 to -0.64; four trials;, Ι²=88%) and BMI (MD -0.45 kg/m2, 95% CI -0.66 to -0.24; three trials; Ι²=0%). Odds of a patient remaining at high risk (as defined in the trial) at the end of the study period were significantly reduced by health checks for cholesterol, blood pressure and BMI but not for smoking.
There was no significant difference between health check and control groups for total mortality (OR 1.03, 95% CI 0.9 to 1.18; four trials; Ι²=7%). CVD mortality was significantly higher in the health check group (OR 1.30, 95% CI 1.02 to 1.66; three trials; Ι²=7%).
Heterogeneity was variable and partly explained by differences in recruitment and follow-up (details in the paper). There was no evidence of publication bias. Results from non-practice-based trials were presented. Meta-regression found no significant differences in effects between practice-based and non-practice-based trials.